Clinical Trial Update: Study of Inotuzumab Ozogamicin Combined to Chemotherapy in Older Patients With Philadelphia Chromosome-negative CD22+ B-cell Precursor ALL [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating inotuzumab ozogamicin combined with chemotherapy in older patients with Ph-negative CD22+ B-cell precursor ALL is ongoing; current stat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia

Drugs mentioned

• Inotuzumab ozogamicin (inotuzumab ozogamicin)

Snippet

Sponsor: Versailles Hospital | Conditions: Acute Lymphoblastic Leukemia (ALL) - Philadelphia Chromosome (Ph)-Negative CD22+ B-cell Precursor (BCP) | Phase 2 | Status: UNKNOWN